Posted Jun. 28, 2010 at 10:45 a.m.

Premium Lock Study: GSK diabetes drug Avandia poses higher risks than a rival product

Published: 2010-06-28 10:45:20
Updated: 2010-06-28 10:45:20

An Avandia package. An Avandia package. (AP)

As many as 100,000 heart attacks, strokes, deaths and cases of heart failure may be due to Avandia since it came on the market in 1999, FDA scientist and Avandia critic tells The Associated Press. GSK spokeswoman says the new study has limitations,...

Read More
Read More

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll